Anchor
Research payments
$1,904,826
Through program year 2025, $1,904,826 in research payments was reported against Anchor, across 11 payments, paid by AstraZeneca Pharmaceuticals LP.
- Paid by
- AstraZeneca Pharmaceuticals LP
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $1,904,826 | 11 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Charlene McEvoy Saint Paul, MN Named on 1 payment
- Michael Paasche-Orlow Boston, MA Named on 1 payment
- David Cypcar Franklin, NC Named on 1 payment
- Nam Le Midway City, CA Named on 1 payment
- Michael Marsh Toluca Lake, CA Named on 1 payment
- John Youssef Flint, MI Named on 1 payment
- James Sublett Louisville, KY Named on 1 payment
- Faith Holmes Austin, TX Named on 1 payment
- Zia Rehman Greenville, NC Named on 1 payment
- Anna Qiu Ann Arbor, MI Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.